메뉴 건너뛰기




Volumn 13, Issue 1, 2010, Pages 148-156

The impact of pharmaceutical cost containment policies on the range of medicines available and subsidized in Finland and New Zealand

Author keywords

Access to medicines; Cost containment policies; Cross national comparison; Drug utilization; Finland; New Zealand; Pharmaceutical policy; Prescription medicines

Indexed keywords

ACARBOSE; ANGIOTENSIN II ANTAGONIST; ANTACID AGENT; ANTIALLERGIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIOBESITY AGENT; BENZYDAMINE; BISMUTH CITRATE; BOSENTAN; CALCIUM CHANNEL BLOCKING AGENT; CHARCOAL; CHOLINE SALICYLATE; HYDRALAZINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LAXATIVE; MERCAPTAMINE; METHYLDOPA; MEXILETINE; MIGLUSTAT; NATEGLINIDE; NICOTINIC ACID; NITISINONE; PERHEXILINE; REPAGLINIDE; SCOPOLAMINE; SCOPOLAMINE BUTYL BROMIDE; SUCRALFATE; TRIAMCINOLONE; UNINDEXED DRUG; VASODILATOR AGENT;

EID: 72949088644     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1111/j.1524-4733.2009.00598.x     Document Type: Article
Times cited : (26)

References (44)
  • 1
    • 2642554902 scopus 로고    scopus 로고
    • European Observatory on Health Care Systems. Online report. Available from. [Accessed January 15, 2009]
    • French S, Old A, Healy J. New Zealand. Health care systems in transition 2001 3 : 1 66. European Observatory on Health Care Systems. Online report. Available from: http://www.euro.who.int/observatory/Hits/20020525-1 [Accessed January 15, 2009].
    • (2001) New Zealand. Health Care Systems in Transition , vol.3 , pp. 1-66
    • French, S.1    Old, A.2    Healy, J.3
  • 2
    • 67651132325 scopus 로고    scopus 로고
    • Finland: Health system review
    • Mladovsly, P. Mossialos, E. eds. Brussels, Belgium. European Observatory on Health Systems and Policies. Online report. Available from. [Accessed January 15, 2009]
    • Vuorenkoski L. Finland: health system review. In : Mladovsly P, Mossialos E, eds. Health Systems in Transition (Vol. 10). 2008 : 1 72. Brussels, Belgium : European Observatory on Health Systems and Policies. Online report. Available from: http://www.euro.who.int/observatory/Hits/20020525-1 [Accessed January 15, 2009].
    • (2008) Health Systems in Transition , vol.10 , pp. 1-72
    • Vuorenkoski, L.1
  • 3
    • 1642571450 scopus 로고    scopus 로고
    • Organisation for Economic Co-operation and Development Available from. [Accessed August 27, 2008]
    • Organisation for Economic Co-operation and Development. Health at a glance 2007: OECD indicators. Available from: http://www.oecd.org/health/ healthataglance [Accessed August 27, 2008].
    • Health at A Glance 2007: OECD Indicators
  • 4
    • 36849075335 scopus 로고    scopus 로고
    • Organisation for Economic Co-operation and Development Available from. [Accessed July 15, 2008]
    • Organisation for Economic Co-operation and Development. OECD health data 2007. Available from: http://www.oecd.org/health/healthdata [Accessed July 15, 2008].
    • OECD Health Data 2007
  • 5
    • 85031338472 scopus 로고    scopus 로고
    • Pharmaceutical Management Agency Available from. [Accessed August 15, 2008]
    • Pharmaceutical Management Agency. About PHARMAC - important events in PHARMAC's history. Available from: http://www.pharmac.govt.nz/ [Accessed August 15, 2008].
    • About PHARMAC - Important Events in PHARMAC's History
  • 6
    • 0033429890 scopus 로고    scopus 로고
    • Managing pharmaceutical expenditure while increasing access. the pharmaceutical management agency (PHARMAC) experience
    • Braae R, McNee W, Moore D. Managing pharmaceutical expenditure while increasing access. The pharmaceutical management agency (PHARMAC) experience. Pharmacoeconomics 1999 16 : 649 660.
    • (1999) Pharmacoeconomics , vol.16 , pp. 649-660
    • Braae, R.1    McNee, W.2    Moore, D.3
  • 7
    • 72949117700 scopus 로고    scopus 로고
    • Pharmaceutical policies in Finland - Challenges and opportunities
    • European Observatory on Health Systems and Policies. Prepared at the request of the Health Department, Ministry of Social Affairs and Health, Finland
    • Mossialos E, Srivastava D. Pharmaceutical policies in Finland - challenges and opportunities. Observatory Studies Series Vol. 10. European Observatory on Health Systems and Policies. Prepared at the request of the Health Department, Ministry of Social Affairs and Health, Finland, 2008.
    • (2008) Observatory Studies Series , vol.10
    • Mossialos, E.1    Srivastava, D.2
  • 8
    • 85031338315 scopus 로고    scopus 로고
    • Pharmaceutical pricing and reimbursement information project commissioned by European Commission, Health and Consumer Protection Directorate-General and the Austrian Ministry of Health, Family and Youth
    • Available from Accessed June 4, 2008]
    • Peura S, Rajaniemi S, Kurkijarvi U. Pharmaceutical Pricing and Reimbursement Information project commissioned by European Commission, Health and Consumer Protection Directorate-General and the Austrian Ministry of Health, Family and Youth. PPRI Pharma profile - FINLAND. 2007. Available from: http://ppri.oebig.at/ [Accessed June 4, 2008].
    • (2007) PPRI Pharma Profile -FINLAND
    • Peura, S.1    Rajaniemi, S.2    Kurkijarvi, U.3
  • 9
    • 14944376871 scopus 로고    scopus 로고
    • The impact of price regulation on the launch delay of new drugs - Evidence from twenty-five major markets in the 1990s
    • Danzon PM, Wang R, Wang L. The impact of price regulation on the launch delay of new drugs - evidence from twenty-five major markets in the 1990s. Health Econ 2005 14 : 269 293.
    • (2005) Health Econ , vol.14 , pp. 269-293
    • Danzon, P.M.1    Wang, R.2    Wang, L.3
  • 10
    • 0023187848 scopus 로고
    • Payment restrictions for prescription drugs under Medicaid. Effects on therapy, cost, and equity
    • Soumerai SB, Avorn J, Ross-Degnan D, et al. Payment restrictions for prescription drugs under Medicaid. Effects on therapy, cost, and equity. N Engl J Med 1989 317 : 550 556.
    • (1989) N Engl J Med , vol.317 , pp. 550-556
    • Soumerai, S.B.1    Avorn, J.2    Ross-Degnan, D.3
  • 11
    • 0025933465 scopus 로고
    • Effects of medicaid drug-payment limits on admission to hospitals and nursing homes
    • Soumerai SB, Ross-Degnan D, Avorn J, et al. Effects of medicaid drug-payment limits on admission to hospitals and nursing homes. N Engl J Med 1991 325 : 1072 1077.
    • (1991) N Engl J Med , vol.325 , pp. 1072-1077
    • Soumerai, S.B.1    Ross-Degnan, D.2    Avorn, J.3
  • 12
    • 0038387480 scopus 로고    scopus 로고
    • Dilemmas in regulation of the market for pharmaceuticals
    • Maynard A, Bloor K. Dilemmas in regulation of the market for pharmaceuticals. Health Aff 2003 22 : 31 41.
    • (2003) Health Aff , vol.22 , pp. 31-41
    • Maynard, A.1    Bloor, K.2
  • 13
    • 34547760765 scopus 로고    scopus 로고
    • Patient access to pharmaceuticals: An international comparison
    • Cohen J, Faden L, Predaris S, et al. Patient access to pharmaceuticals: an international comparison. Eur J Health Econ 2007 8 : 253 267.
    • (2007) Eur J Health Econ , vol.8 , pp. 253-267
    • Cohen, J.1    Faden, L.2    Predaris, S.3
  • 14
    • 0034092435 scopus 로고    scopus 로고
    • The cost of prescription medicines to patients
    • Noyce PR, Huttin C, Atella V, et al. The cost of prescription medicines to patients. Health Policy 2000 52 : 129 145.
    • (2000) Health Policy , vol.52 , pp. 129-145
    • Noyce, P.R.1    Huttin, C.2    Atella, V.3
  • 15
    • 26844576001 scopus 로고    scopus 로고
    • European prices of newly launched reimbursable pharmaceuticals - A pilot study
    • Martikainen J, Kivi I, Linnosmaa I. European prices of newly launched reimbursable pharmaceuticals - a pilot study. Health Policy 2005 74 : 235 246.
    • (2005) Health Policy , vol.74 , pp. 235-246
    • Martikainen, J.1    Kivi, I.2    Linnosmaa, I.3
  • 17
    • 72949108931 scopus 로고    scopus 로고
    • Social Insurance Institution. Helsinki, Finland. Social Insurance Institution
    • Social Insurance Institution. Statistical Yearbook of the Social Insurance Institution. Helsinki, Finland : Social Insurance Institution, 2007.
    • (2007) Statistical Yearbook of the Social Insurance Institution.
  • 18
    • 85031337492 scopus 로고    scopus 로고
    • GDP PPPs and derived indices for all OECD countries 2004-2007
    • Organisation for Economic Co-operation and Development Available from. [Accessed June 27, 2008]
    • Organisation for Economic Co-operation and Development. GDP PPPs and derived indices for all OECD countries 2004-2007. Purchasing Power Parities Data. Available from: http://www.oecd.org/document/47/0,3343,en-2649-34357- 36202863-1-1-1-1,00.html#historicalppp [Accessed June 27, 2008].
    • Purchasing Power Parities Data
  • 22
    • 72949124468 scopus 로고    scopus 로고
    • Ministry of Social Affairs and Health Available from. [Accessed June 25, 2008]
    • Ministry of Social Affairs and Health. Pharmaceutical Policy 2010. Publications of the Ministry of Social Affairs and Health 2003:11. Available from: http://www.stm.fi/julkaisut/julkaisujasarja/nayta/-julkaisu/1061593#fi [Accessed June 25, 2008].
    • (2003) Pharmaceutical Policy 2010. Publications of the Ministry of Social Affairs and Health , pp. 11
  • 23
    • 27244439496 scopus 로고    scopus 로고
    • PHARMAC and long-acting insulin analogues: A poor man's insulin pump - But not available to the poor man
    • U1641
    • Krebs J. PHARMAC and long-acting insulin analogues: a poor man's insulin pump - but not available to the poor man. N Z Med J 2005 118 1221) U1641.
    • (2005) N Z Med J , vol.118 , pp. 1221
    • Krebs, J.1
  • 24
    • 23844543827 scopus 로고    scopus 로고
    • Is PHARMAC's sole-supply tendering policy harming the health of New Zealanders?
    • U1433
    • MacKay P. Is PHARMAC's sole-supply tendering policy harming the health of New Zealanders? N Z Med J 2005 118 1214) U1433.
    • (2005) N Z Med J , vol.118 , pp. 1214
    • MacKay, P.1
  • 25
    • 1542329750 scopus 로고    scopus 로고
    • Trends in accessibility to medicines for children in New Zealand: 1998-2002
    • Chui J, Tordoff J, Kennedy J, et al. Trends in accessibility to medicines for children in New Zealand: 1998-2002. Br J Clin Pharmacol 2004 57 : 322 328.
    • (2004) Br J Clin Pharmacol , vol.57 , pp. 322-328
    • Chui, J.1    Tordoff, J.2    Kennedy, J.3
  • 26
    • 85031344777 scopus 로고    scopus 로고
    • CPMMedica. MIMS New Ethicals 2007. January-June. New Zealand
    • CPMMedica. MIMS New Ethicals 2007. January-June 2007. Issue 6. New Zealand.
    • (2007) , Issue.6
  • 27
    • 84876669060 scopus 로고    scopus 로고
    • Available from. [Accessed July 19, 2008]
    • Medsafe. Data sheets. Available from: http://www.medsafe.govt.nz/profs/ Datasheet/dsform.asp [Accessed July 19, 2008].
    • Data Sheets
  • 28
    • 85031345853 scopus 로고    scopus 로고
    • Lääketietokeskus. Helsinki, Finland. Laaketietokeskus
    • Lääketietokeskus. Pharmaca Fennica 2007: I-III. Helsinki, Finland : Laaketietokeskus, 2007.
    • (2007) Pharmaca Fennica 2007: I-III
  • 29
    • 35549013688 scopus 로고    scopus 로고
    • Prices for innovative pharmaceutical products that provide health gain: A comparison between Australia and the United States
    • Roughead E, Lopert R, Sansom LN. Prices for innovative pharmaceutical products that provide health gain: a comparison between Australia and the United States. Value Health 2007 10 : 514 520.
    • (2007) Value Health , vol.10 , pp. 514-520
    • Roughead, E.1    Lopert, R.2    Sansom, L.N.3
  • 30
    • 85031333392 scopus 로고    scopus 로고
    • Food and Drug Administration Available from. [Accessed August 20, 2008]
    • Food and Drug Administration. CDER fast track products approved since 1998 through 3/31/07. Available from: http://www.fda.gov/Drugs/ DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ DrugandBiologicApprovalReports/FastTrackApprovalReports/ucm082380.htm [Accessed August 20, 2008].
    • CDER Fast Track Products Approved since 1998 Through 3/31/07
  • 32
    • 77249144053 scopus 로고    scopus 로고
    • The WHO Collaborating Centre for Drug Statistics Methodology Available from. [Accessed July 8, 2008]
    • The WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD index 2008. Available from: http://www.whocc.no/atcddd/ [Accessed July 8, 2008].
    • ATC/DDD Index 2008
  • 33
    • 85031336718 scopus 로고    scopus 로고
    • Sweetman SC, ed. (35th. ed.). London. Pharmaceutical Press. Publications division of the Royal Pharmaceutical Society of Great Britain
    • Sweetman SC, ed. Martindale: The Complete Drug Reference (35th ed.). London : Pharmaceutical Press. Publications division of the Royal Pharmaceutical Society of Great Britain, 2008.
    • (2008) Martindale: The Complete Drug Reference
  • 34
    • 33646432626 scopus 로고    scopus 로고
    • Food and Drug Administration Available from. [Accessed August 8, 2008]
    • Food and Drug Administration. Electronic orange book. Available from: http://www.fda.gov/cder/ob/ [Accessed August 8, 2008].
    • Electronic Orange Book
  • 35
    • 84875268677 scopus 로고    scopus 로고
    • Available from. [Accessed July 19, 2008]
    • Medsafe. Product/application search. Available from: http://afssapsprd. afssaps.fr/php/ecodex/index.php [Accessed July 19, 2008].
    • Product/application Search
  • 36
    • 84879392801 scopus 로고    scopus 로고
    • Agence Française de Securité Sanitaire des Produits de Santé (AFSSPS) Available from. [Accessed August 15, 2008]
    • Agence Française de Securité Sanitaire des Produits de Santé (AFSSPS). Répertoire des specialites pharmaceutiques. Available from: http://afssapsprd.afssaps.fr/php/ecodex/index.php [Accessed August 15, 2008].
    • Répertoire des Specialites Pharmaceutiques
  • 37
    • 85031344523 scopus 로고    scopus 로고
    • National Agency for Medicines Available from. [Accessed July 19, 2008]
    • National Agency for Medicines. NamWeb haku. Available from: http://namweb.nam.fi/namweb/do/haku/view?locale=fi [Accessed July 19, 2008].
    • NamWeb Haku
  • 38
    • 85031342625 scopus 로고    scopus 로고
    • Medical Products Agency (Läkemedelsverket) Available from. [Accessed July 28, 2008]
    • Medical Products Agency (Läkemedelsverket). Läkemedelsfakta. Available from: http://www.lakemedelsverket.se/Tpl/ProduktSearchPage-1231.aspx [Accessed July 28, 2008].
    • Läkemedelsfakta
  • 39
    • 37249007168 scopus 로고    scopus 로고
    • European Medicines Agency Available from. [Accessed July 9, 2008]
    • European Medicines Agency. EPARs for authorised medicinal products for human use. Available from: http://www.emea.europa.eu/htms/human/epar/eparintro. htm [Accessed July 9, 2008].
    • EPARs for Authorised Medicinal Products for Human Use
  • 40
    • 77955798710 scopus 로고    scopus 로고
    • Food and Drug Administration Available from. [Accessed August 8, 2008]
    • Food and Drug Administration. Drugs@FDA. Available from: http://www.accessdata.fda.gov/Scripts/cder/DrugsatFDA/ [Accessed August 8, 2008].
    • Drugs@FDA
  • 41
    • 0031851417 scopus 로고    scopus 로고
    • International price comparisons for pharmaceuticals. Measurement and policy issues
    • Danzon PM, Kim JD. International price comparisons for pharmaceuticals. Measurement and policy issues. Pharmacoeconomics 1998 14 : 115 128.
    • (1998) Pharmacoeconomics , vol.14 , pp. 115-128
    • Danzon, P.M.1    Kim, J.D.2
  • 42
    • 15244359182 scopus 로고    scopus 로고
    • Reference pricing of pharmaceuticals for Medicare: Evidence from Germany, the Netherlands, and New Zealand
    • Danzon PM, Kelcham JD. Reference pricing of pharmaceuticals for Medicare: evidence from Germany, The Netherlands, and New Zealand. Front Health Policy Res 2004 7 : 1 54.
    • (2004) Front Health Policy Res , vol.7 , pp. 1-54
    • Danzon, P.M.1    Kelcham, J.D.2
  • 43
    • 72949114908 scopus 로고    scopus 로고
    • Kalleimpien kolesterolilääkkeiden korvattavuutta rajataan
    • Tokola O. Kalleimpien kolesterolilääkkeiden korvattavuutta rajataan. TABU 2006 3 : 29.
    • (2006) TABU , vol.3 , pp. 29
    • Tokola, O.1
  • 44
    • 85031332789 scopus 로고    scopus 로고
    • European Central Bank Available from. [Accessed February 12, 2009]
    • European Central Bank. Exchange rate 1.6.2007: NZ$1.8163= US$1.3436=1. Available from: http://www.ecb.org [Accessed February 12, 2009].
    • Exchange Rate 1.6.2007: NZ$1.8163=US$1.3436=1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.